Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.510
-0.030 (-1.95%)
At close: Feb 6, 2026, 4:00 PM EST
1.550
+0.040 (2.65%)
After-hours: Feb 6, 2026, 7:56 PM EST
Pyxis Oncology Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$6.75
Upside
+347.02%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +231.13% | Dec 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $7 | Strong Buy | Maintains | $5 → $7 | +363.58% | Dec 19, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $5 → $8 | Buy | Maintains | $5 → $8 | +429.80% | Nov 24, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $5 → $7 | Strong Buy | Maintains | $5 → $7 | +363.58% | Nov 4, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +231.13% | Sep 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +231.13% | Aug 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +231.13% | May 19, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $8 | Buy | Reiterates | $8 | +429.80% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +231.13% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 → $5 | Strong Buy | Reiterates | $7 → $5 | +231.13% | Dec 20, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $10 → $8 | Buy | Reiterates | $10 → $8 | +429.80% | Dec 20, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $7 → $10 | Buy | Maintains | $7 → $10 | +562.25% | Nov 21, 2024 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +363.58% | Nov 21, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $13 | Buy | Initiates | $13 | +760.93% | Nov 8, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $7 | Buy | Reiterates | $7 | +363.58% | Sep 19, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.